Golden State Wealth Management LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.9% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 1,647 shares of the healthcare conglomerate’s stock after selling 67 shares during the quarter. Golden State Wealth Management LLC’s holdings in UnitedHealth Group were worth $863,000 at the end of the most recent quarter.
Several other hedge funds have also recently made changes to their positions in the business. Brighton Jones LLC lifted its holdings in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the period. Bank Pictet & Cie Europe AG grew its stake in UnitedHealth Group by 3.9% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock worth $133,373,000 after purchasing an additional 9,872 shares during the period. Proficio Capital Partners LLC lifted its position in UnitedHealth Group by 52.1% during the fourth quarter. Proficio Capital Partners LLC now owns 3,734 shares of the healthcare conglomerate’s stock valued at $1,889,000 after buying an additional 1,279 shares during the period. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $32,000. 87.86% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Price Performance
Shares of UnitedHealth Group stock opened at $308.69 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The stock has a 50 day moving average of $324.99 and a 200 day moving average of $447.68. The firm has a market cap of $280.03 billion, a PE ratio of 12.93, a PEG ratio of 1.48 and a beta of 0.45.
UnitedHealth Group Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a $2.21 dividend. The ex-dividend date was Monday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 37.02%.
Analyst Ratings Changes
A number of equities analysts have weighed in on the stock. KeyCorp decreased their target price on shares of UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating for the company in a research note on Monday, June 2nd. UBS Group cut their target price on UnitedHealth Group from $400.00 to $385.00 and set a “buy” rating on the stock in a research note on Wednesday, June 25th. Morgan Stanley lowered their price target on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Finally, TD Securities reiterated a “hold” rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $415.57.
Check Out Our Latest Research Report on UnitedHealth Group
Insiders Place Their Bets
In related news, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kristen Gil bought 3,700 shares of the firm’s stock in a transaction dated Thursday, May 15th. The shares were acquired at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director owned 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is currently owned by company insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- What Are Trending Stocks? Trending Stocks Explained
- The Apple Comeback Will Be Better Than the Setback
- Energy and Oil Stocks Explained
- How a Government Loan Changes the Game for Plug Power
- How Can Investors Benefit From After-Hours Trading
- Qualcomm’s Hold Rating Misses Strong Growth Story
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.